Skip to main content

Conexeu Sciences Inc.

corporate_fare Company Profile

Conexeu Sciences Inc.

CNXU·NASDAQ·Industrial Applications And Services·CIK 0002066836

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for medical aesthetics and tissue repair. The company offers patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform. This platform is used in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring, specifically for face, breast, and butt volume restoration. Conexeu Sciences Inc. also has CXU collagen gel, an investigational product. This gel targets therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data. These products are positioned as alternatives to conventional fillers or implants. Currently, the products are investigational and are pending regulatory clearance for certain applications. Conexeu Sciences Inc. serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors. This includes clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

Conexeu Sciences Inc. (NASDAQ:CNXU) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for CNXU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for CNXU spans S-1, 8-K, 10-Q, 424B3.

Recent high-impact activity:

  • Conexeu Registers 7.73M Shares for Resale; Up to $14.3M Warrant Proceeds Possible
  • Conexeu Offers 1-for-1 Inducement Warrants to Pull Forward $2.30 Warrants
  • Conexeu Details $5M Private Placement: 1.33M Units at $3.00, Insider $250K Escrowed for Vote
  • $5M Private Placement Led by CEO and Insiders Funds Path to Q1 2027 FDA Filing
  • Conexeu Sciences Q3 Loss Widens to $7.7M; Cash Runway Shrinks, Going Concern Warning Reiterated

Short Interest & Short Volume

1.12 days to cover

FINRA reported short interest of 429,836 shares in CNXU as of the October 30, 2026 settlement, a 44.6% increase from the prior period — about 1.1 days to cover at its recent average daily volume. On November 20, 2026, 66.0% of CNXU volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)429,836 shares as of October 30, 2026
Change vs prior period▲ 44.6%
Days to cover1.12 at avg daily volume of 383,560
Daily short volume (FINRA facilities)66.0% of 383,872 shares on November 20, 2026
5-day average short volume55.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for CNXU, detected from its recent SEC filings · based on capital-structure filings through 2026-10-29.

2 recent capital raises1 shelf registration

Highly Dilutive Offering · Going Concern Warning

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$1.58 +1.94% today
52-week range · as of 2026-11-19 $1.58 – $18.79
Market cap
$47.79M
Volume
683.6K (1.9× avg)
3-mo avg 360.2K
Live data · 2026-11-21 19:31 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CNXU - Latest Insights

CNXU
Nov 19, 2026, 4:30 PM EST
Filing Type: S-1
Importance Score:
7
Price at Filing: $2.05
Real-time Price: $1.58 info
Change: -$0.470 (-23%) info
Market Cap: $47.787M info
CNXU
Oct 27, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.90
Real-time Price: $1.58 info
Change: -$1.32 (-46%) info
Market Cap: $47.787M info
CNXU
Oct 20, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.28
Real-time Price: $1.58 info
Change: -$1.70 (-52%) info
Market Cap: $47.787M info
CNXU
Oct 15, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.80
Real-time Price: $1.58 info
Change: -$2.22 (-58%) info
Market Cap: $47.787M info
CNXU
Sep 14, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.00
Real-time Price: $1.58 info
Change: -$3.42 (-68%) info
Market Cap: $47.787M info
CNXU
Sep 10, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $1.58 info
Change: -$2.67 (-63%) info
Market Cap: $47.787M info
CNXU
Jul 14, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $10.82
Real-time Price: $1.58 info
Change: -$9.24 (-85%) info
Market Cap: $47.787M info
CNXU
Jul 07, 2026, 5:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.49
Real-time Price: $1.58 info
Change: -$7.91 (-83%) info
Market Cap: $47.787M info
CNXU
Jun 25, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $10.94
Real-time Price: $1.58 info
Change: -$9.36 (-86%) info
Market Cap: $47.787M info
CNXU
Jun 15, 2026, 8:42 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $11.20
Real-time Price: $1.58 info
Change: -$9.62 (-86%) info
Market Cap: $47.787M info
CNXU
Jun 15, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.82
Real-time Price: $1.58 info
Change: -$8.24 (-84%) info
Market Cap: $47.787M info
CNXU
May 21, 2026, 12:02 PM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $13.21
Real-time Price: $1.58 info
Change: -$11.63 (-88%) info
Market Cap: $47.787M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets